Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.

Axel Bauer; Nikolay Sappler; Lukas von Stülpnagel; Mathias Klemm; Michael Schreinlechner; Felix Wenner; Johannes Schier; Amani Al Tawil; Theresa Dolejsi; Aresa Krasniqi; Elodie Eiffener; Christa Bongarth; Markus Stühlinger; Martin Huemer; Tommaso Gori; Reza Wakili; Riza Sahin; Robert Schwinger; Matthias Lutz; Armin Luik; Nele Gessler; Peter Clemmensen; Axel Linke; Lars S Maier; Martin Hinterseer; Mathias C Busch; Florian Blaschke; Stefan Sack; Carsten Lennerz; Manuela Licka; Roland R Tilz; Christian Ukena; Joachim R Ehrlich; Markus Zabel; Georg Schmidt; Ulrich Mansmann; Stefan Kääb; Konstantinos D Rizas; Steffen Massberg

doi:10.1016/S2589-7500(21)00253-3

Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.

Axel Bauer, Nikolay Sappler, Lukas von Stülpnagel, Mathias Klemm, Michael Schreinlechner, Felix Wenner, Johannes Schier, Amani Al Tawil, Theresa Dolejsi, Aresa Krasniqi, Elodie Eiffener, Christa Bongarth, Markus Stühlinger, Martin Huemer, Tommaso Gori, Reza Wakili, Riza Sahin (Co-author), Robert Schwinger, Matthias Lutz, Armin LuikNele Gessler, Peter Clemmensen, Axel Linke, Lars S Maier, Martin Hinterseer, Mathias C Busch, Florian Blaschke, Stefan Sack, Carsten Lennerz, Manuela Licka, Roland R Tilz, Christian Ukena, Joachim R Ehrlich, Markus Zabel, Georg Schmidt, Ulrich Mansmann, Stefan Kääb, Konstantinos D Rizas, Steffen Massberg

Department of Internal Medicine VIII, Division of Cardiology

Research output: Contribution to journal › Original Article › peer-review

14 Citations (Web of Science)

Original language	English
Pages (from-to)	e105-e116
Journal	LANCET DIGITAL HEALTH
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/S2589-7500(21)00253-3
Publication status	Published - 2022

Keywords

VENTRICULAR EJECTION FRACTION
HEART-RATE-VARIABILITY
POSTINFARCTION PATIENTS
DECELERATION CAPACITY
ATRIAL-FIBRILLATION
MORTALITY
SUDDEN
STRATIFICATION
PREDICTION
DEATH

Access to Document

10.1016/S2589-7500(21)00253-3

Cite this

Bauer, A., Sappler, N., von Stülpnagel, L., Klemm, M., Schreinlechner, M., Wenner, F., Schier, J., Al Tawil, A., Dolejsi, T., Krasniqi, A., Eiffener, E., Bongarth, C., Stühlinger, M., Huemer, M., Gori, T., Wakili, R., Sahin, R., Schwinger, R., Lutz, M., ... Massberg, S. (2022). Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. LANCET DIGITAL HEALTH, 4(2), e105-e116. https://doi.org/10.1016/S2589-7500(21)00253-3

Bauer, Axel ; Sappler, Nikolay ; von Stülpnagel, Lukas et al. / Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. In: LANCET DIGITAL HEALTH. 2022 ; Vol. 4, No. 2. pp. e105-e116.

@article{88f826bb2d8948868637e711cfa5aaa6,

title = "Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.",

keywords = "VENTRICULAR EJECTION FRACTION, HEART-RATE-VARIABILITY, POSTINFARCTION PATIENTS, DECELERATION CAPACITY, ATRIAL-FIBRILLATION, MORTALITY, SUDDEN, STRATIFICATION, PREDICTION, DEATH",

author = "Axel Bauer and Nikolay Sappler and {von St{\"u}lpnagel}, Lukas and Mathias Klemm and Michael Schreinlechner and Felix Wenner and Johannes Schier and {Al Tawil}, Amani and Theresa Dolejsi and Aresa Krasniqi and Elodie Eiffener and Christa Bongarth and Markus St{\"u}hlinger and Martin Huemer and Tommaso Gori and Reza Wakili and Riza Sahin and Robert Schwinger and Matthias Lutz and Armin Luik and Nele Gessler and Peter Clemmensen and Axel Linke and Maier, {Lars S} and Martin Hinterseer and Busch, {Mathias C} and Florian Blaschke and Stefan Sack and Carsten Lennerz and Manuela Licka and Tilz, {Roland R} and Christian Ukena and Ehrlich, {Joachim R} and Markus Zabel and Georg Schmidt and Ulrich Mansmann and Stefan K{\"a}{\"a}b and Rizas, {Konstantinos D} and Steffen Massberg",

note = "Sahin: Department of Cardiology, Paracelsus Medical University N{\"u}rnberg, Germany",

year = "2022",

doi = "10.1016/S2589-7500(21)00253-3",

language = "English",

volume = "4",

pages = "e105--e116",

journal = "LANCET DIGITAL HEALTH",

issn = "2589-7500",

number = "2",

}

Bauer, A, Sappler, N, von Stülpnagel, L, Klemm, M, Schreinlechner, M, Wenner, F, Schier, J, Al Tawil, A, Dolejsi, T, Krasniqi, A, Eiffener, E, Bongarth, C, Stühlinger, M, Huemer, M, Gori, T, Wakili, R, Sahin, R, Schwinger, R, Lutz, M, Luik, A, Gessler, N, Clemmensen, P, Linke, A, Maier, LS, Hinterseer, M, Busch, MC, Blaschke, F, Sack, S, Lennerz, C, Licka, M, Tilz, RR, Ukena, C, Ehrlich, JR, Zabel, M, Schmidt, G, Mansmann, U, Kääb, S, Rizas, KD & Massberg, S 2022, 'Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.', LANCET DIGITAL HEALTH, vol. 4, no. 2, pp. e105-e116. https://doi.org/10.1016/S2589-7500(21)00253-3

Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. / Bauer, Axel; Sappler, Nikolay; von Stülpnagel, Lukas et al.
In: LANCET DIGITAL HEALTH, Vol. 4, No. 2, 2022, p. e105-e116.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.

AU - Bauer, Axel

AU - Sappler, Nikolay

AU - von Stülpnagel, Lukas

AU - Klemm, Mathias

AU - Schreinlechner, Michael

AU - Wenner, Felix

AU - Schier, Johannes

AU - Al Tawil, Amani

AU - Dolejsi, Theresa

AU - Krasniqi, Aresa

AU - Eiffener, Elodie

AU - Bongarth, Christa

AU - Stühlinger, Markus

AU - Huemer, Martin

AU - Gori, Tommaso

AU - Wakili, Reza

AU - Sahin, Riza

AU - Schwinger, Robert

AU - Lutz, Matthias

AU - Luik, Armin

AU - Gessler, Nele

AU - Clemmensen, Peter

AU - Linke, Axel

AU - Maier, Lars S

AU - Hinterseer, Martin

AU - Busch, Mathias C

AU - Blaschke, Florian

AU - Sack, Stefan

AU - Lennerz, Carsten

AU - Licka, Manuela

AU - Tilz, Roland R

AU - Ukena, Christian

AU - Ehrlich, Joachim R

AU - Zabel, Markus

AU - Schmidt, Georg

AU - Mansmann, Ulrich

AU - Kääb, Stefan

AU - Rizas, Konstantinos D

AU - Massberg, Steffen

N1 - Sahin: Department of Cardiology, Paracelsus Medical University Nürnberg, Germany

PY - 2022

Y1 - 2022

KW - VENTRICULAR EJECTION FRACTION

KW - HEART-RATE-VARIABILITY

KW - POSTINFARCTION PATIENTS

KW - DECELERATION CAPACITY

KW - ATRIAL-FIBRILLATION

KW - MORTALITY

KW - SUDDEN

KW - STRATIFICATION

KW - PREDICTION

KW - DEATH

U2 - 10.1016/S2589-7500(21)00253-3

DO - 10.1016/S2589-7500(21)00253-3

M3 - Original Article

C2 - 35090674

SN - 2589-7500

VL - 4

SP - e105-e116

JO - LANCET DIGITAL HEALTH

JF - LANCET DIGITAL HEALTH

IS - 2

ER -

Bauer A, Sappler N, von Stülpnagel L, Klemm M, Schreinlechner M, Wenner F et al. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. LANCET DIGITAL HEALTH. 2022;4(2):e105-e116. doi: 10.1016/S2589-7500(21)00253-3